CROI 2016 Program at a Glance

Keyword Index

Astrocyte - 393 Asymptomatic infection - 72LB Atazanavir/ritonavir - 417, 428, 692, 753, 774 Atherosclerosis - 640, 654, 656, 658, 673 Atorvastatin - 551 Atripla - 706, 945 Attrition - 118 Awareness - 974 –B– B cell responses - 127, 324 B cells - 127 B-type Natriuretic Peptide (BNP) - 646 Bacterial functions - 474 Bacterial translocation - 187, 239 Balance - 895 Barriers to care - 1016, 1042 Basal ganglia - 823 BCG - 824 Behavioral - 55, 917, 931, 934, 969, 993 Big data - 4 Bimolecular fluorescence complementation (BiFC) - 191 Biodegradable implant - 879 Bioenergetics - 144 Bioinformatics - 260, 481, 950 Biomarker - 276, 342, 410, 540, 660, 671, 685, 691, 715, 865, 939 Birth outcomes - 799 Birth PCR - 783, 785 Bispecific antibodies - 94 Bispecific antibodies - 469LB Black MSM - 893, 897, 930 Blimp-1 - 153 Blood pressure - 677 BMS-626529 - 460, 472 BMS-663068 - 460, 472 BMS-955176 - 425, 464, 466 Body composition - 40, 722 Body mass index - 677 Bone - 36, 40, 46, 47, 699, 819 • Renal safety - 808 • Disease - 46, 126, 694, 698 • Marrow - 365 • Marrowmonocytes/ macrophages - 403 • Mineral density (BMD) – 48LB, 695LB, 696, 698, 859

• turnover markers - 47, 126, 694, 859 Boosted - 452 Botswana - 37, 111, 784, 802, 805, 810, 904, 984 Brain - 175, 822 Brain structure - 384, 386, 387, 388, 389 Breakthrough HIV Infection - 479LB Breastfeeding and breast milk – 441, 449, 828 Broadly neutralizing antibodies - 32LB, 89LB, 90, 186, 302, 309LB 303, 311LB Bryostatin-1 - 354 BST-2/Tetherin - 181, 246 Burden of disease - 52, 679 Bystander pathogenesis - 243 –C– Cabotegravir - 31LB, 71, 105, 106, 881 Canada - 622 Cancer - 86, 160, 162, 331, 613, 620, 622, 629, 811 • Risk - 604, 615 • Stage - 614 • Survival - 614, 615, 616 Cannabinoid receptor 2 - 557 Capsid - 196, 197 Cardiac abnormalities - 853 Cardiometabolic health - 722 Cardiovascular - 41, 646, 659, 660, 671 Cardiovascular disease - 43, 636, 638, 640, 642, 644, 646, 648, 650, 653, 655, 658, 662, 664, 665, 673, 675, 676, 687, 854 – • Risk factors - 636, 637, 642, 644, 646, 647, 659, 661, 662, 666, 675, 704, 711, 715, 722, 914 Cardiovascular markers - 657 Care retention - 993, 1002, 1042 CARE+ - 997 Care-delivery model - 68, 534 Carotid intima-media thickness - 643, 651, 656, 672, 674 cART - 160, 295, 382, 569, 831 Cascade of care - 28, 120, 1042, 1043, 1051

Case-control study - 293, 640, 824 Caspase-1 - 241 Caspase-3/7 - 241 Causal inference methods - 942 Cause of death - 941 Cause-specific mortality - 911, 941 CBFβ - 199, 202 CCR5 - 78, 296, 306, 357, 358LB, 552, 781 CCR5 expression - 242, 655 CCR6 - 188 CD1a - 288 CD34+ hematopoietic stem cells - 295 CD4T cell - 58, 186, 244, 254, 271, 334, 369, 946 • Count - 304, 386, 486, 942 • Death - 187, 241, 243 • Depletion - 188, 262 • Nadir – 386 • Receptor - 191, 193 • Reconstitution - 233, 252 • Recovery - 234, 295, 335, 473, 751 • Response – 944 CD4 CD8 • Ratio - 278, 291, 326, 408, 633, 710, 729 CD8T cell - 248, 269, 274, 312, 313, 407, 732, 827 CD8T cell suppression - 22, 374 CD9 - 250 CDK - 207 Cell activation - 244, 653 Cell associated HIV DNA - 85, 300LB, 330, 349 Cell associated HIV RNA - 85, 245LB, 330 Cell cycle - 183, 207, 251 Cell death - 251, 295, 372 Cell traffic brain macrophages - 141 Cell-free mtDNA - 715 Cell-to-cell infection - 393 Cell-to-cell transmission - 184, 186 Cellular factors/Cytokines - 244 Cellular model - 360 Cenicriviroc - 239 Central fat - 704 Central memoryT cells - 251, 335

Central nervous system (CNS) - 60, 63, 142, 144, 388, 392, 395, 398, 400, 405, 412 Cerebrospinal fluid (CSF) - 404, 405, 407, 411, 412, 413, 446, 767 Cerebrovascular - 43, 640 Cervical cancer - 162, 615, 617, 621, 625 Cervical cancer screening - 162, 623, 624, 625 CHARTER score - 420 Chemokine - 254, 274 Chemokine receptor - 239 Chemsex - 913 Children - 302, 442, 619, 840, 841, 842, 843, 850, 1023 · Child mortality - 802 · Childhood tuberculosis - 746, 748 China - 969, 970 Chlamydia - 922, 1005 Chlamydia trachomatis - 1004, 1006 Cholesterol - 145, 643, 659 Chronic Hepatitis B - 564, 568, 569 Chronic Hepatitis C - 10, 66, 151, 528, 529, 530, 531, 538LB, 548, 574, 581, 583, 587, 604 Chronic HIV infection – 245LB, 387, 396, 403, 528, 654, 673, 708 Chronic Inflammation - 240, 271, 654 Chronic kidney disease - 686, 687, 691 Chronic lung disease - 724, 725 Churn - 992 Circulating recombinant form (CRF) - 213 Circumcision – 165, 987 Cirrhosis - 124, 422, 527, 550, 551, 574, 603, 610 Clade C - 317 Clinical management - 177 Clinical monitoring - 1005 Clinical outcomes - 53, 256, 345, 587, 611, 960 Clinical parameters - 227 Clinical pharmacology - 445, 449, 453, 777, 815

Keyword Index CROI 2016 166